Cited by 125Treatment of Major DepressionFibroblast Growth Factor ResearchNeurotransmitter Receptor Influence on Behavior

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Antidepressant-like effects of intracerebroventricular FGF2 in rats

Open access

Turner, Cortney A., Gula, Edny L., Taylor, Larry P., Watson, Stanley J., Akil, Huda·2008·Brain Research

DOI 10.1016/j.brainres.2008.05.088PMC PMC2532793

Open this paper in CoChat — free account

Abstract

The fibroblast growth factor (FGF) system is altered in post-mortem brains of individuals with major depressive disorder (MDD), but the functional relevance of this observation remains to be elucidated. To this end, we tested whether administering agents that act on FGF receptors would have antidepressant-like effects in rodents. We microinjected either FGF2 (200 ng, i.c.v.) or the FG loop (FGL) of neural cell adhesion molecule (NCAM) (5 microg, i.c.v.) into the lateral ventricle of rats and tested them on the forced swim test. Activating FGF receptors acutely had an antidepressant-like effect in the forced swim test. Furthermore, chronic FGF2 decreased depression-like behavior as assessed by two independent tests. Finally, the FGF system itself was altered after FGF2 administration. Specifically, there was an increase in FGFR1 mRNA in the dentate gyrus 24 h post-FGF2, suggesting the potential for self-amplification of the initial signal. These results support the potential therapeutic use of FGF2 or related molecules in the treatment of MDD and point to alternate mechanisms of neuronal remodeling that may be critical in this treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.brainres.2008.05.088

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,525
Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
Berton, O., McClung, C. A., DiLeone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., et al. (2006) · Science · doi:10.1126/science.1120972 · Cited by 2,129
The mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059
Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654
Epidermal Growth Factor and Fibroblast Growth Factor-2 Have Different Effects on Neural Progenitors in the Adult Rat Brain
Kuhn, H. G., Winkler, J., Kempermann, G., Thal, L. J., & Gage, F. H. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-15-05820.1997 · Cited by 1,214
The forced swimming test as a model for core and component behavioral effects of antidepressant drugs
Lucki, I. (1997) · Behavioural Pharmacology · doi:10.1097/00008877-199711000-00010 · Cited by 803
Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover proliferation, and survival in the adult dentate gyrus
Sairanen, M., Lucas, G., Ernfors, P., Castrén, M., & Castrén, E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3741-04.2005 · Cited by 763
Activation of the FGF receptor underlies neurite outgrowth stimulated by L1, N-CAM, and N-cadherin
Williams, E. J., Furness, J., Walsh, F. S., & Doherty, P. (1994) · Neuron · doi:10.1016/0896-6273(94)90027-2 · Cited by 585
Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors
Monteggia, L. M., Luikart, B., Barrot, M., Theobold, D., Malkovska, I., Nef, S., Parada, L. F., & Nestler, E. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.021 · Cited by 502
Dysregulation of the fibroblast growth factor system in major depression
Evans, S. J., Choudary, P. V., Neal, C. R., Li, J. Z., Vawter, M. P., Tomita, H., Lopez, J. F., Thompson, R. C., Meng, F., Stead, J. D., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406788101 · Cited by 424
Self-citation

Show all 33 references

Sorted by citations

The FGF family: biology, pathophysiology and therapy
Beenken, A., & Mohammadi, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2792 · Cited by 1,945
Revisiting the Stress Concept: Implications for Affective Disorders
McEwen, B. S., & Akil, H. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.0733-19.2019 · Cited by 686
“…FGF2 functions as a resilience factor, protecting animals against social defeat stress, enhancing extinction of learned fear, and decreasing anxiety behavior in animals genetically bred for high vulnerability to stress (Turner et al., 2008,b, 2011, 2012; Perez et al., 2009; Prater et al., 2017).”
BackgroundSelf-citation
The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications
Moylan, S., Maes, M., Wray, N. R., & Berk, M. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.33 · Cited by 529
The role of 5-HT receptors in depression
Yohn, C. N., Gergues, M. M., & Samuels, B. A. (2017) · Molecular Brain · doi:10.1186/s13041-017-0306-y · Cited by 485
Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression
Bernard, R., Kerman, I. A., Thompson, R. C., Jones, E. G., Bunney, W. E., Barchas, J. D., Schatzberg, A. F., Myers, R. M., Akil, H., & Watson, S. J. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.44 · Cited by 372
Self-citation
Facilitation of AMPA Receptor Synaptic Delivery as a Molecular Mechanism for Cognitive Enhancement
Knafo, S., Venero, C., Sánchez‐Puelles, C., Pereda-Pérez, I., Franco, A. C. G., Sandi, C., Suárez, L. M., Solís, J. M., Alonso‐Nanclares, L., Martín, E. D., et al. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001262 · Cited by 313
Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression
Levy, M. J. F., Boulle, F., Steinbusch, H. W., van den Hove, D. L. A., Kenis, G., & Lanfumey, L. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4950-4 · Cited by 308
The Hippocampus, Neurotrophic Factors and Depression
Masi, G., & Brovedani, P. (2011) · CNS Drugs · doi:10.2165/11595900-000000000-00000 · Cited by 271
Fibroblast growth factor (FGF) signaling in development and skeletal diseases
Teven, C. M., Farina, E. M., Rivas, J., & Reid, R. R. (2014) · Genes & Diseases · doi:10.1016/j.gendis.2014.09.005 · Cited by 237
From Cradle to Grave: The Multiple Roles of Fibroblast Growth Factors in Neural Development
Guillemot, F., & Zimmer, C. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.002 · Cited by 241
Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression
Duman, R. S. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.3/rsduman · Cited by 210
Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes
Allaman, I., Fiumelli, H., Magistretti, P. J., & Martin, J. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2190-y · Cited by 216
Disialic, oligosialic and polysialic acids: distribution, functions and related disease
Sato, C., & Kitajima, K. (2013) · The Journal of Biochemistry · doi:10.1093/jb/mvt057 · Cited by 182
Antidepressant Effects of Fibroblast Growth Factor-2 in Behavioral and Cellular Models of Depression
Elsayed, M., Banasr, M., Duric, V., Fournier, N. M., Licznerski, P., & Duman, R. S. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.03.003 · Cited by 169
The Fibroblast Growth Factor Family: Neuromodulation of Affective Behavior
Turner, C. A., Watson, S. J., & Akil, H. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.037 · Cited by 160
Self-citation
Suicide neurobiology
Ernst, C., Mechawar, N., & Turecki, G. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.09.001 · Cited by 166
Polysialic acid: Biosynthesis, novel functions and applications
Colley, K., Kitajima, K., & Sato, C. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2014.976606 · Cited by 154
A New Role for FGF2 as an Endogenous Inhibitor of Anxiety
Perez, J. A., Clinton, S. M., Turner, C. A., Watson, S. J., & Akil, H. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4829-08.2009 · Cited by 146
Self-citation
Target Identification for CNS Diseases by Transcriptional Profiling
Altar, C. A., Vawter, M. P., & Ginsberg, S. D. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.172 · Cited by 139
Mesenchymal stem cells increase hippocampal neurogenesis and counteract depressive-like behavior
Tfilin, M., Sudai, E., Merenlender, A., Gispan, I. H., Yadid, G., & Turgeman, G. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.110 · Cited by 131
Fibroblast Growth Factor Receptor 1– 5-Hydroxytryptamine 1A Heteroreceptor Complexes and Their Enhancement of Hippocampal Plasticity
Borroto‐Escuela, D. O., Romero‐Fernandez, W., Mudò, G., Pérez‐Alea, M., Ciruela, F., Tarakanov, A. O., Narváez, M., Liberto, V. D., Agnati, L. F., Belluardo, N., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.09.012 · Cited by 126
Growth factors as clinical biomarkers of prognosis and diagnosis in psychiatric disorders
Galvez-Contreras, A. Y., Campos-Ordonez, T., Lopez-Virgen, V., Gomez-Plascencia, J., Ramos-Zuniga, R., & Gonzalez-Perez, O. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.08.004 · Cited by 112
Novel Regulation of Fibroblast Growth Factor 2 (FGF2)-mediated Cell Growth by Polysialic Acid
Ono, S., Hane, M., Kitajima, K., & Sato, C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.276618 · Cited by 105
Interplay between pro-inflammatory cytokines and growth factors in depressive illnesses
Audet, M., & Anisman, H. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00068 · Cited by 107
From synapse to nucleus: Novel targets for treating depression
Covington, H. E., Vialou, V., & Nestler, E. J. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.12.004 · Cited by 98
Fibroblast growth factor-2 (FGF2) augmentation early in life alters hippocampal development and rescues the anxiety phenotype in vulnerable animals
Turner, C. A., Clinton, S. M., Thompson, R. C., Watson, S. J., & Akil, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103732108 · Cited by 96
Self-citation
Neural stem cell regulation, fibroblast growth factors, and the developmental origins of neuropsychiatric disorders
Stevens, H. E. (2010) · Frontiers in Neuroscience · doi:10.3389/fnins.2010.00059 · Cited by 90
Secretin as a neurohypophysial factor regulating body water homeostasis
Chu, J., Lee, L. T. O., Lai, C., Vaudry, H., Chan, Y., Yung, W., & Chow, B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903695106 · Cited by 88
Expression and Functions of Fibroblast Growth Factor 2 (FGF-2) in Hippocampal Formation
Zechel, S., Werner, S., Unsicker, K., & Halbach, O. V. B. U. (2010) · The Neuroscientist · doi:10.1177/1073858410371513 · Cited by 87
Polysialylation and disease
Sato, C., & Kitajima, K. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100892 · Cited by 87
Antidepressant Acts on Astrocytes Leading to an Increase in the Expression of Neurotrophic/Growth Factors: Differential Regulation of FGF-2 by Noradrenaline
Kajitani, N., Hisaoka‐Nakashima, K., Morioka, N., Okada‐Tsuchioka, M., Kaneko, M., Kasai, M., Shibasaki, C., Nakata, Y., & Takebayashi, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051197 · Cited by 87
Uncovering the molecular basis of positive affect using rough-and-tumble play in rats: a role for insulin-like growth factor I
Burgdorf, J. S., Kroes, R. A., Beinfeld, M. C., Panksepp, J., & Moskal, J. R. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.03.045 · Cited by 74
Dysregulated fibroblast growth factor (FGF) signaling in neurological and psychiatric disorders
Turner, C. A., Eren‐Koçak, E., Inui, E. G., Watson, S. J., & Akil, H. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.10.003 · Cited by 75
Self-citation
Fibroblast Growth Factor 2‐Mediated Regulation of Neuronal Exosome Release Depends on VAMP3/Cellubrevin in Hippocampal Neurons
Kumar, R., Tang, Q., Müller, S. A., Gao, P., Mahlstedt, D., Zampagni, S., Tan, Y., Klingl, A., Bötzel, K., Lichtenthaler, S. F., et al. (2020) · Advanced Science · doi:10.1002/advs.201902372 · Cited by 69
Adult hippocampal neurogenesis: Is it the alpha and omega of antidepressant action?
Eliwa, H., Belzung, C., & Surget, A. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.08.005 · Cited by 73
FGF21 Attenuated LPS-Induced Depressive-Like Behavior via Inhibiting the Inflammatory Pathway
Wang, X., Zhu, L., HU, J. L., Guo, R., Ye, S., Liu, F., Wang, D., Zhao, Y., Hu, A., Wang, X., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00154 · Cited by 71
Fibroblast Growth Factors in Depression
Deng, Z. H., Deng, S., Zhang, M.-R., & Tang, M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00060 · Cited by 68
Fibroblast Growth Factor 2 Modulates Hypothalamic Pituitary Axis Activity and Anxiety Behavior Through Glucocorticoid Receptors
Salmaso, N., Stevens, H. E., McNeill, J., ElSayed, M., Ren, Q., Maragnoli, M. E., Schwartz, M. L., Tomasi, S., Sapolsky, R. M., Duman, R. S., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.02.026 · Cited by 67
Neural Stem Cell Grafting Counteracts Hippocampal Injury-Mediated Impairments in Mood, Memory, and Neurogenesis
Hattiangady, B., & Shetty, A. K. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0050 · Cited by 63
Fibroblast Growth Factors in Neurodevelopment and Psychopathology
van Scheltinga, A. F. T., Bakker, S. C., Kahn, R. S., & Kas, M. J. (2013) · The Neuroscientist · doi:10.1177/1073858412472399 · Cited by 60
Effects of Monoamines and Antidepressants on Astrocyte Physiology: Implications for Monoamine Hypothesis of Depression
Marathe, S. V., D’almeida, P., Virmani, G., Bathini, P., & Alberi, L. A. (2018) · Journal of Experimental Neuroscience · doi:10.1177/1179069518789149 · Cited by 62
Tricyclic Antidepressant Amitriptyline Activates Fibroblast Growth Factor Receptor Signaling in Glial Cells
Hisaoka, K., Tsuchioka, M., Yano, R., Maeda, N., Kajitani, N., Morioka, N., Nakata, Y., & Takebayashi, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.224683 · Cited by 57
FGF2 blocks PTSD symptoms via an astrocyte-based mechanism
Xia, L., Zhai, M., Wang, L., Miao, D., Xia Shuang, Z. H. U., & Wang, W. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.08.048 · Cited by 57
Fibroblast growth factor 9 is a novel modulator of negative affect
Aurbach, E. L., Inui, E. G., Turner, C. A., Hagenauer, M. H., Prater, K. E., Li, J. Z., Absher, D., Shah, N., Blandino, P., Bunney, W. E., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510456112 · Cited by 57
Self-citation
Short-Hairpin RNA Silencing of Endogenous Fibroblast Growth Factor 2 in Rat Hippocampus Increases Anxiety Behavior
Eren‐Koçak, E., Turner, C. A., Watson, S. J., & Akil, H. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.11.020 · Cited by 53
Self-citation
Hippocampal astrocytes are necessary for antidepressant treatment of learned helplessness rats
Iwata, M., Shirayama, Y., Ishida, H., Hazama, G., & Nakagome, K. (2010) · Hippocampus · doi:10.1002/hipo.20803 · Cited by 54
Neuroplastin‐55 binds to and signals through the fibroblast growth factor receptor
Owczarek, S., Kiryushko, D. V., Larsen, M. H., Kastrup, J. S., Gajhede, M., Sandi, C., Berezin, V., Bock, E., & Soroka, V. (2009) · The FASEB Journal · doi:10.1096/fj.09-140509 · Cited by 51
Impact of structural aberrancy of polysialic acid and its synthetic enzyme ST8SIA2 in schizophrenia
Sato, C., & Kitajima, K. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00061 · Cited by 50
The Monoaminergic Tripartite Synapse: A Putative Target for Currently Available Antidepressant Drugs
Quesseveur, G., Gardier, A. M., & Guiard, B. P. (2013) · Current Drug Targets · doi:10.2174/13894501113149990209 · Cited by 55
Antidepressant-Like Effects of Low- and High-Molecular Weight FGF-2 on Chronic Unpredictable Mild Stress Mice
Wang, L., Li, X., Chen, X., Qin, X., Kardami, E., & Cheng, Y. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00377 · Cited by 50
FGFR1–5-HT1A Heteroreceptor Complexes: Implications for Understanding and Treating Major Depression
Borroto‐Escuela, D. O., Tarakanov, A. O., & Fuxé, K. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.11.003 · Cited by 50
Learning and Memory Depend on Fibroblast Growth Factor Receptor 2 Functioning in Hippocampus
Stevens, H. E., Jiang, G. Y., Schwartz, M. L., & Vaccarino, F. M. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.03.013 · Cited by 48
Fibroblast Growth Factor-2 Enhances Extinction and Reduces Renewal of Conditioned Fear
Graham, B. M., & Richardson, R. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.3 · Cited by 44
Cell encapsulation enhances antidepressant effect of the mesenchymal stem cells and counteracts depressive-like behavior of treatment-resistant depressed rats
Kin, K., Yasuhara, T., Kameda, M., Tomita, Y., Umakoshi, M., Kuwahara, K., Kin, I., Kidani, N., Morimoto, J., Okazaki, M., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0208-0 · Cited by 44
Protective effects of polysialic acid on proteolytic cleavage of FGF2 and proBDNF/BDNF
Hane, M., Matsuoka, S., Ono, S., Miyata, S., Kitajima, K., & Sato, C. (2015) · Glycobiology · doi:10.1093/glycob/cwv049 · Cited by 42
Decreased serum fibroblast growth factor - 2 levels in pre- and post-treatment patients with major depressive disorder
Shen, H., Zhang, T., Hong, B., Peng, D., Su, H. L., Lin, Z., Fang, Y., Jiang, K., Liu, X., & Li, H. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.07.035 · Cited by 39
Anxiolytic effects of muscarinic acetylcholine receptors agonist oxotremorine in chronically stressed rats and related changes in BDNF and FGF2 levels in the hippocampus and prefrontal cortex
Liberto, V. D., Frinchi, M., Verdi, V., Vitale, A., Plescia, F., Cannizzaro, C., Massenti, M. F., Belluardo, N., & Mudò, G. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4498-0 · Cited by 41
Fibroblast growth factor 2 is necessary for the antidepressant effects of fluoxetine
Simard, S., Shail, P., MacGregor, J., Sayed, M. E., Duman, R. S., Vaccarino, F. M., & Salmaso, N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204980 · Cited by 41
Fibroblast Growth Factor 2 in the Dorsomedial Striatum Is a Novel Positive Regulator of Alcohol Consumption
Even‐Chen, O., Sadot-Sogrin, Y., Shaham, O., & Barak, S. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0890-17.2017 · Cited by 38
The mood stabilizer valproate activates human FGF 1 gene promoter through inhibiting HDAC and GSK ‐3 activities
Kao, C., Hsu, Y., Liu, J., Lee, D., Chung, Y., & Chiu, I. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12292 · Cited by 41
Roles of exogenous and endogenous FGF-2 in animal models of depression
Jarosik, J., Legutko, B., Werner, S., Unsicker, K., & Halbach, O. V. B. U. (2011) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-2011-0588 · Cited by 37
Trazodone regulates neurotrophic/growth factors, mitogen-activated protein kinases and lactate release in human primary astrocytes
Daniele, S., Zappelli, E., & Martini, C. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0446-x · Cited by 36
Unraveling the Role of the Blood-Brain Barrier in the Pathophysiology of Depression: Recent Advances and Future Perspectives
Varghese, S. M., Patel, S., Nandan, A., Jose, A., Ghosh, S., Sah, R. K., Menon, B., Athira, K. V., & Chakravarty, S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04205-5 · Cited by 39
Exploring pharmacological options for adolescent depression: a preclinical evaluation with a sex perspective
Ledesma‐Corvi, S., Hernández‐Hernández, E., & García-Fuster, M. J. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01994-y · Cited by 33
Nose-to-brain delivery of hyaluronate – FG loop peptide conjugate for non-invasive hypoxic-ischemic encephalopathy therapy
Kim, Y. S., Sung, D. K., Kim, H., Kong, W. H., Kim, Y., & Hahn, S. K. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.06.021 · Cited by 31
Effect of basic fibroblast growth factor (FGF2) gene polymorphisms on SSRIs treatment response and side effects
Kato, M., Okugawa, G., Wakeno, M., Takekita, Y., Nonen, S., Tetsuo, S., Nishida, K., Azuma, J., Kinoshita, T., & Serretti, A. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.06.006 · Cited by 31
Inhibition of FGF Receptor-1 Suppresses Alcohol Consumption: Role of PI3 Kinase Signaling in Dorsomedial Striatum
Even‐Chen, O., & Barak, S. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0805-19.2019 · Cited by 30
Neonatal FGF2 alters cocaine self-administration in the adult rat
Turner, C. A., Capriles, N., Flagel, S. B., Perez, J. A., Clinton, S. M., Watson, S. J., & Akil, H. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.10.018 · Cited by 29
Self-citation
Disturbance of prefrontal cortical myelination in olfactory bulbectomized mice is associated with depressive-like behavior
Takahashi, K., Kurokawa, K., Hong, L., Miyagawa, K., Mochida-Saito, A., Takeda, H., & Tsuji, M. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105112 · Cited by 28
Sialic Acids in Neurology
Sato, C., & Kitajima, K. (2018) · Advances in carbohydrate chemistry and biochemistry · doi:10.1016/bs.accb.2018.09.003 · Cited by 27
Connective Tissue Growth Factor Is a Novel Prodepressant
Turner, C. A., Sharma, V., Hagenauer, M. H., Chaudhury, S., O’Connor, A. M., Hebda‐Bauer, E. K., Thompson, R. C., Myers, R., Bunney, W. E., Barchas, J. D., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.04.013 · Cited by 26
Self-citation
Involvement of FGF-2 modulation in the antidepressant-like effects of liquiritin in mice
Chen, M., Zhang, Q., Zhu, J., Cheng, J., Liu, Q., Xu, G., Li, C., & Yi, L. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173297 · Cited by 26
Heterogeneity in major depressive disorder: The need for biomarker-based personalized treatments
Suseelan, S., & Pinna, G. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2022.09.001 · Cited by 27
Selectively Bred Rats Provide a Unique Model of Vulnerability to PTSD-Like Behavior and Respond Differentially to FGF2 Augmentation Early in Life
Prater, K. E., Aurbach, E. L., Larcinese, H. K., Smith, T. N., Turner, C. A., Blandino, P., Watson, S. J., Maren, S., & Akil, H. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.37 · Cited by 26
Self-citation
Intraamygdala Infusion of Fibroblast Growth Factor 2 Enhances Extinction and Reduces Renewal and Reinstatement in Adult Rats
Graham, B. M., & Richardson, R. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3014-11.2011 · Cited by 25
Trophic factors as potential therapies for treatment of major mental disorders
Dremencov, E., Ježová, D., Barak, S., Gaburjáková, J., Gaburjáková, M., Kútna, V., & Ovsepian, S. V. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136194 · Cited by 25
Adaptation to single housing is dynamic: Changes in hormone levels, gene expression, signaling in the brain, and anxiety-like behavior in adult male C57Bl/6J mice
Hebda‐Bauer, E. K., Dokas, L. A., Watson, S. J., & Akil, H. (2019) · Hormones and Behavior · doi:10.1016/j.yhbeh.2019.06.005 · Cited by 23
Self-citation
Increased negative affect when combining early-life maternal deprivation with adolescent, but not adult, cocaine exposure in male rats: regulation of hippocampal FADD
Bis‐Humbert, C., García‐Cabrerizo, R., & García-Fuster, M. J. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05689-4 · Cited by 23
Fibroblast growth factor 2 regulates activity and gene expression of human post‐mitotic excitatory neurons
Gupta, S., Redmond, T. M., Meng, F., Tidball, A. M., Akil, H., Watson, S. J., Parent, J. M., & Uhler, M. D. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14255 · Cited by 22
Self-citation
NCAM Mimetic Peptides: Potential Therapeutic Target for Neurological Disorders
Chu, C., Gao, Y., Lan, X., Thomas, A., & Shen, L. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2594-8 · Cited by 21
Adolescent morphine induces emotional signs of withdrawal paired with neurotoxicity selectively in male rats: Female resilience
Jiménez-Romero, F., Bis‐Humbert, C., & García-Fuster, M. J. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134625 · Cited by 21
FGF-2 induces neuronal death through upregulation of system xc-.
Liu, X., Albano, R., & Lobner, D. (2014) · Brain Research · doi:10.1016/j.brainres.2013.12.018 · Cited by 22
Neurogenesis within the adult hippocampus under physiological conditions and in depression.
Dokter, M., & Halbach, O. V. B. U. (2012) · Europe PMC (PubMed Central) · doi:10.3969/j.issn.1673-5374.2012.07.013 · Cited by 19
MiR-497 promotes microglia activation and proinflammatory cytokines production in chronic unpredictable stress-induced depression via targeting FGF2
Zhai, X., Liu, J., Ni, A., & Ye, J. (2020) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2020.101872 · Cited by 18
FGF2 is an endogenous regulator of alcohol reward and consumption
Even‐Chen, O., Herburg, L., Kefalakes, E., Urshansky, N., Grothe, C., & Barak, S. (2021) · Addiction Biology · doi:10.1111/adb.13115 · Cited by 18
Fibroblast Growth Factor-2: An Endogenous Antidepressant and Anxiolytic Molecule?
Turner, C. A., Watson, S. J., & Akil, H. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.05.025 · Cited by 15
Self-citation
Effects of early-life FGF2 on ultrasonic vocalizations (USVs) and the mu-opioid receptor in male Sprague-Dawley rats selectively-bred for differences in their response to novelty
Turner, C. A., Hagenauer, M. H., Aurbach, E. L., Maras, P. M., Fournier, C. L., Blandino, P., Chauhan, R. B., Panksepp, J., Watson, S. J., & Akil, H. (2019) · Brain Research · doi:10.1016/j.brainres.2019.03.011 · Cited by 15
Self-citation
5-HT1A receptor-mediated phosphorylation of extracellular signal-regulated kinases (ERK1/2) is modulated by regulator of G protein signaling protein 19
Wang, Q., Terauchi, A., Yee, C., Umemori, H., & Traynor, J. R. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.04.017 · Cited by 14
New Approaches to the Pharmacological Management of Major Depressive Disorder
Witkin, J. M., & Li, X. (2009) · Advances in pharmacology · doi:10.1016/s1054-3589(08)57009-8 · Cited by 14
Abnormalities in FGF family members and their roles in modulating depression‐related molecules
Xu, Y., Zhu, Y., Zhu, Y., Wei, H., Zhang, N., Qin, J., Zhu, X., Yu, M., & Li, Y. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14570 · Cited by 13
Dynamic modulation of basic Fibroblast Growth Factor (FGF-2) expression in the rat brain following repeated exposure to cocaine during adolescence
Giannotti, G., Caffino, L., Calabrese, F., Racagni, G., & Fumagalli, F. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2840-8 · Cited by 13
Neural cell adhesion molecule peptide mimetics modulate emotionality: pharmacokinetic and behavioral studies in rats and non-human primates
Turner, C. A., Lyons, D. M., Buckmaster, C. L., Aurbach, E. L., Watson, S. J., Schatzberg, A. F., & Akil, H. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0052-6 · Cited by 12
Self-citation
Role of nociceptin/orphanin FQ and nociceptin opioid peptide receptor in depression and antidepressant effects of nociceptin opioid peptide receptor antagonists
Park, J. Y., Chae, S., Kim, C. S., Kim, Y. J., Yi, H. J., Han, E.-J., Joo, Y., Hong, S., Yun, J. W., Kim, H., et al. (2019) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2019.23.6.427 · Cited by 13
Basic fibroblast growth factor increased glucocorticoid receptors in cortical neurons through MAP kinase pathway
Numakawa, T., Odaka, H., Adachi, N., Chiba, S., Ooshima, Y., Matsuno, H., Nakajima, S., Yoshimura, A., Fumimoto, K., Hirai, Y., et al. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.06.009 · Cited by 12
Effects of FGF receptor peptide agonists on animal behavior under normal and pathological conditions
Rudenko, O., Tkach, V., Berezin, V., & Bock, E. (2010) · Neuroscience Research · doi:10.1016/j.neures.2010.05.002 · Cited by 11
Neurotrophic Factors and Antidepressant Action: Recent Advances
O’Leary, O. F., & Ċastrén, E. (2010) · Modern trends in psychiatry · doi:10.1159/000319514 · Cited by 11
Environmental enrichment and physical exercise prevent stress-induced social avoidance and blood-brain barrier alterations via Fgf2
Paton, S. E. J., Solano, J. L., Cadoret, A., Collignon, A., Binder, L. B., Daigle, B., Bevilacqua, L. M., Richer, É., Coulombe-Rozon, F., Dion‐Albert, L., et al. (2026) · Nature Communications · doi:10.1038/s41467-025-68058-9 · Cited by 11
GPCR oligomerization as a target for antidepressants: Focus on GPR39
Młyniec, K., Siodłak, D., Doboszewska, U., & Nowak, G. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107842 · Cited by 9
Fast-acting antidepressant-like effects of ketamine in aged male rats
Hernández‐Hernández, E., Ledesma‐Corvi, S., Jornet-Plaza, J., & García-Fuster, M. J. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00636-y · Cited by 7
Sprouty2 in the Dorsal Hippocampus Regulates Neurogenesis and Stress Responsiveness in Rats
Dow, A. L., Lin, T. V., Chartoff, E. H., Potter, D. N., McPhie, D. L., Veer, A. V., Knoll, A. T., Lee, K. N., Neve, R. L., Patel, T. B., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120693 · Cited by 8

Authors: Turner, C. A., Gula, E. L., Taylor, L. P., Watson, S. J., & Akil, H.
Affiliations: University of Michigan (US)
Corresponding author: Turner, Cortney A.
ORCID: Turner, Cortney A.
Watson, Stanley J.
Akil, Huda
Venue: Brain Research
Publisher: Elsevier BV
Published: 2008-08
Volume: 1224
Pages: 63-68
ISSN: 0006-8993 (ISSN-L)
DOI: 10.1016/j.brainres.2008.05.088
PMC: PMC2532793
OpenAlex: W1978696776
Cited by: 125
References: 33
Citations by year: 2026: 3 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 4 · 2021: 4 · 2020: 9 · 2019: 9 · 2018: 11 · 2017: 6 · 2016: 4 · 2015: 8 · 2014: 5 · 2013: 11 · 2012: 11
FWCI: 7.74
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Brain Research (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of Mental Health (MH042251, MH060398, P50MH060398, P01MH042251)
National Institute on Drug Abuse (DA007267, P01DA021633, DA007268, T32DA007268, T32DA007267, DA021633)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords: fibroblast growth factor 2, antidepressant-like effects, major depressive disorder, fibroblast growth factor receptor, FG loop, CD56, dentate gyrus, forced swim test, depression-like behavior, intracerebroventricular microinjection, neuronal remodeling, FGF signaling
MeSH terms: Animals, Behavior, Animal, Brain, Depressive Disorder, Disease Models, Animal, Injections, Intraventricular, Male, Neuropsychological Tests, RNA, Messenger, Stress, Psychological, Fibroblast Growth Factor 2, Rats, Sprague-Dawley, In Situ Hybridization, Dentate Gyrus, Rats, Receptor, Fibroblast Growth Factor, Type 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Antidepressant-like effects of intracerebroventricular FGF2 in rats

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks